Century Therapeutics(IPSC)
$1.74+0.06 (+3.57%)
IPSC
Century Therapeutics financials statements
$1.74
At close:+0.06 (+3.57%)
Want to see IPSC full AI Analyst Report?
Century Therapeutics (IPSC) Income Statement
297 Followers
Century Therapeutics Income Statement
Last quarter (Q2 2026), Century Therapeutics's total revenue was $0.00. In Q2, Century Therapeutics's net income was $-34.55M. See Century Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 109.16M | $ 6.59M | $ 2.23M | $ 5.20M | $ 0.00 | |
| $ 96.06M | $ 6.59M | $ 2.23M | $ 5.20M | $ -4.58M | |
| $ 111.10M | $ 144.73M | $ 148.78M | $ 139.03M | $ 90.30M | |
| Depreciation and Amortization | $ 13.10M | $ 13.30M | $ 13.04M | $ 8.44M | $ 3.75M |
| $ 3.45M | $ -111.47M | $ -121.21M | $ -121.20M | $ -90.76M | |
| $ -15.04M | $ -138.14M | $ -146.55M | $ -133.83M | $ -94.88M | |
| $ 5.39M | $ 13.36M | $ 11.75M | $ 2.99M | $ -898.00K | |
| $ -9.65M | $ -124.78M | $ -134.79M | $ -130.84M | $ -95.78M | |
| $ -9.58M | $ -126.57M | $ -136.67M | $ -130.93M | $ -95.82M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.11 | $ -1.61 | $ -2.30 | $ -2.27 | $ -1.74 |
| Diluted EPS | $ -0.11 | $ -1.61 | $ -2.30 | $ -2.27 | $ -1.74 |
| Weighted Average Shares Outstanding | 86.56M | 78.65M | 59.31M | 57.76M | 55.01M |
| Weighted Average Shares Outstanding (Diluted) | 86.56M | 78.65M | 59.31M | 57.76M | 55.01M |
Currency in USD
